Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC TIPIRACIL-200MG
SDP

Catalog No. 5000570030
Encompass_Preferred

Tipiracil (CAS No 183204-74-2) is a thymidine phosphorylase inhibitor primarily studied in the context of cancer research It originates from the development of combination therapies aimed at enhancing the efficacy of chemotherapeutic agents Tipiracil functions by inhibiting the enzyme thymidine phosphorylase which is involved in nucleotide metabolism ultimately affecting tumor growth and angiogenesis Its common in vitro activity is observable in the nanomolar to low micromolar range making it effective in various biochemical assays and cellular models In research applications Tipiracil is frequently used in combination with other drugs like trifluridine in cell culture studies animal models and preclinical drug screenings to assess antitumor potential Experimental concentrations typically depend on the specific research design allowing for flexibility in dosing strategies to fit the research aim

Catalog No. 50-005-70030 Supplier Apexbio Technology LLC Supplier No. BA3519200
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Tipiracil (CAS No 183204-74-2) is a thymidine phosphorylase inhibitor primarily studied in the context of cancer research It originates from the development of combination therapies aimed at enhancing the efficacy of chemotherapeutic agents Tipiracil functions by inhibiting the enzyme thymidine phosphorylase which is involved in nucleotide metabolism ultimately affecting tumor growth and angiogenesis Its common in vitro activity is observable in the nanomolar to low micromolar range making it effective in various biochemical assays and cellular models In research applications Tipiracil is frequently used in combination with other drugs like trifluridine in cell culture studies animal models and preclinical drug screenings to assess antitumor potential Experimental concentrations typically depend on the specific research design allowing for flexibility in dosing strategies to fit the research aim

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.